Comparing Dry Needling and Botulinum Toxin for Post-Stroke Spasticity
Official title: Comparative Study of the Mechanism of Action of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity: a Proof of Concept Controlled Trial
Run by Universiteit Antwerpen · NCT06296082 · Data updated 2026-11-12
This study is testing whether dry needling can help reduce muscle tightness in the legs of stroke survivors just as well as a common injection treatment.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Universiteit Antwerpen Academic / other |
| Locations | 3 sites (Antwerp, Flanders and 2 other locations) |
| Status | Recruiting |
| Started | September 1, 2024 |
| Main results expected | December 30, 2026 |
| Study ends | March 29, 2027 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT06296082 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-75 who have experienced their first stroke within the last 12 months and exhibit ankle plantar flexor spasticity.
✕Probably not a fit
Patients with medical conditions that interfere with data interpretation or those who have contraindications for BTX-A or DN treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial is a randomized parallel group study conducted in Spain, Canada, and Belgium, aimed at comparing the effectiveness of Botulinum Toxin type A (BTX-A) and Dry Needling (DN) in treating lower limb spasticity in patients who have experienced a first stroke within the last 12 months. Participants will be randomly assigned to receive either one session of BTX-A or 12 weekly sessions of DN. The study will assess the effects of these treatments on spasticity using blinded evaluators before, during, and after treatment, with a follow-up at four weeks. The primary hypothesis is that DN will have comparable effects to BTX-A in reducing spasticity by decreasing stretch reflex excitability.
Why it matters
Potential benefit: If successful, this study could provide an effective alternative treatment for post-stroke spasticity, improving mobility and quality of life for patients.
How similar studies have gone: Other studies have shown promising results with similar approaches, but this specific comparison of DN and BTX-A is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. aged 18-75 years. 2. post-stroke spasticity in ankle plantar flexors (Modified Ashworth Scale (MAS) scores of 1-2). 3. first stroke. 4. 0-12 months evolution. 5. no previous BTX-A or DN treatment for spasticity. 6. ankle passive range of motion ≥ 20° (approximately) with knee flexion \~30°. 7. independent ambulation with or without aids. Exclusion Criteria: 1. medical conditions interfering with data interpretation. 2. contraindications for BTX-A or DN treatment. 3. changes in anti-spasticity medication dosage (if appropriate), either during the trial or within the 3 months prior to participation. 4. pregnant or breastfeeding.
Where it's running
-
Universiteit Antwerpen
Antwerp, Flanders, Belgium Recruiting -
Jewish Rehabilitation Hospital
Montreal, Quebec, Canada Recruiting -
Hospital Clínico Universitario Lozano Blesa
Zaragoza, Zaragoza, Spain Recruiting
Study contacts
- Principal investigator: Pablo Herrero Gallego, PhD — Universidad de Zaragoza
- Study coordinator: Pablo Herrero Gallego, PhD
- Email: pherrero@unizar.es
- Phone: +34646168248
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.